编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
---|---|---|---|---|
1781503 | 1H-吡唑并[3,4-C]吡啶 | 271-47-6 | 96.0% | |
1H-吡唑并[3,4-C]吡啶,1H-pyrazolo[3,4-c]pyridine | ||||
178815 | H-89盐酸盐 | 130964-39-5 | 98.0% | |
H-89是一种特殊的腺苷酸环酶抑制剂(DDA),是一种循环的氨依赖性蛋 | ||||
2017872 | HDM201 | 1448867-41-1 | 98.0% | |
HDM201是一种口服生物利用率在人的同源基因(HDM2)抑制剂。具有潜在 | ||||
17022709 | HM-61713 (BI-1482694) | 1802181-20-9 | 98% | |
BI-1482694是布鲁顿酪氨酸激酶(BTK)的一种有效的小分子抑制剂。 | ||||
17021403 | 5-羟基吡嗪-2-羧酸 | 34604-60-9 | 98% | |
5-羟基吡嗪-2-羧酸, 一种抗结核药物吡嗪酰胺(PZA)的代谢物。 | ||||
17011902 | Hesperadin | 422513-13-1 | 98% | |
Hesperadin是人类Aurora B的一种抑制剂,它可以阻止IC(50)为40 nM的基质 | ||||
16122819 | HLCL-61 HCl | 1158279-20-9 | 98% | |
HLCL-61 is a potent and selective PRMT5 inhibitor for treatment of acute myeloid leuk | ||||
16122818 | Hexaminolevulinate HCl | 140898-91-5 | 98% | |
Hexaminolevulinate hydrochloride, also known as hexyl 5-aminolevulinate HCl, is the h | ||||
16122816 | HA15 | 1609402-14-3 | 98% | |
HA15 displayed anti-cancerous activity on all melanoma cells tested, including cells | ||||
161009024 | Honokiol | 35354-74-6 | 98% by HPLC | |
Houpu has traditionally been used in Eastern medicine as analgesic and to treat anxie | ||||
161009001 | HS-173 | 1276110-06-5 | 98% by HPLC | |
HS-173 inhibited the PI3K signaling pathway, and showed anti-proliferative effects on | ||||
16062902 | HUHS015 | 1453097-13-6 | 98% by HPLC | |
HUHS015 is a potent PCA-1/ALKBH3 inhibitor both in vitro and in vivo. The bioavailabi | ||||
16062204 | HLCL-61 | 586395-74-6 | 98% by HPLC | |
HLCL-61 is a potent and selective PRMT5 inhibitor for treatment of acute myeloid leuk | ||||
032511 | 1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylic Acid | 156270-06-3 | 98% | |
Coming soon! | ||||
032503 | 1H-Indazole-5-boronic acid | 338454-14-1 | 98% | |
Coming soon! | ||||
011306 | HTH-01-015 | 1613724-42-7 | 98% | |
HTH-01-015 is a potent and selective inhibitor of NUAK1 with IC50 of 100 nM, does not | ||||
010402 | hydrocortisone | 50-23-7 | 98% | |
Hydrocortisone is the main glucocorticoid secreted by the ADRENAL CORTEX. Its synthet | ||||
121507 | HQL-79 | 162641-16-9 | 98% | |
Coming soon! | ||||
103003 | HBED-CC-PSMA ( PSMA-11 ) | 1366302-52-4 | 97% | |
PSMA-11, also known as HBED-CC-PSMA or Psma-hbed-CC, has potential use as a tracer fo | ||||
103002 | HBED-CC | 143557-99-7 | 98.0% | |
Coming soon! | ||||
92218 | 6-hydroxy-N-Methylbenzofuran-3-carboxaMide | 98% | ||
Coming soon! | ||||
91706 | 7-hydroxy-1H-quinolin-2-one | 70500-72-0 | 98% | |
Coming soon! | ||||
90608 | 3-(4-Hydroxyphenyl)propionic acid | 501-97-3 | 98% | |
Coming soon! | ||||
81930 | 6-Hydroxy-1-indanone | 62803-47-8 | 98% | |
Coming soon! | ||||
81003 | 2H-Isoindole-1-carboxylic acid methyl ester | 56365-71-0 | 97% | |
Coming soon! | ||||
52732 | 6H05 | 1469338-01-9 | 98% | |
6H05 is a selective, and allosteric inhibitor of oncogenic mutant K-Ras(G12C | ||||
52581 | HMN-214 | 173529-46-9 | 98% | |
HMN-214(IVX214) is a potent PLK1 inhibitor an average IC50 of 0.12 M. | ||||
52535 | HPGDS inhibitor 1 | 1033836-12-2 | 98% | |
HPGDS inhibitor 1 is a novel and selective Hematopoietic Prostaglandin D Synthase (HP | ||||
52015 | HSP990 (NVP-HSP990) | 934343-74-5 | 98% | |
NVP-HSP990 (HSP990) is a novel, potent and selectiveHSP90inhibitor for HSP90/ withIC5 |